CNSP
Closed
Cns Pharmaceuticals Inc
0.8511
+0.0261 (+3.16%)
Last Update: 01 Jul 2025 23:10:00
Yesterday: 0.825
Day's Range: 0.800001 - 0.8799
Send
sign up or login to leave a comment!
When Written:
1
CNS Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing novel treatments for primary and metastatic cancers of the brain and central nervous system. The company's lead drug candidate, Berubicin, is a promising anthracycline chemotherapy agent that has shown efficacy in preclinical studies against a range of brain cancers, including glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer.
CNS Pharmaceuticals Inc is headquartered in Houston, Texas, and was founded in 2017. The company is publicly traded on the NASDAQ stock exchange under the ticker symbol "CNSP."
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
CNS Pharmaceuticals Inc is headquartered in Houston, Texas, and was founded in 2017. The company is publicly traded on the NASDAQ stock exchange under the ticker symbol "CNSP."
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








